Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
about
Ischemic heart disease in women: a focus on risk factorsHeart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationPartial nephrectomy versus radical nephrectomy for clinically localized renal massesInterventions for improving health literacy in people with chronic kidney diseaseDietary patterns for adults with chronic kidney diseaseAltered dietary salt intake for people with chronic kidney diseaseHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisAntiplatelet agents for chronic kidney diseaseGlucose targets for preventing diabetic kidney disease and its progressionAntiplatelet agents for chronic kidney diseaseAltered dietary salt intake for chronic kidney diseaseAntiplatelet agents for chronic kidney diseaseInterventions for lowering plasma homocysteine levels in dialysis patientsHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisAdiponectin regulates albuminuria and podocyte function in miceRenalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure.New loci associated with kidney function and chronic kidney diseaseHyperphosphatemia of chronic kidney diseaseAssociation of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul StudyGuidelines for the management of chronic kidney diseaseInterventions for lowering plasma homocysteine levels in dialysis patientsHomocysteine in Renal InjuryMyocardial arterial spin labelingRole of Myeloperoxidase in Patients with Chronic Kidney DiseaseThe role of neoadjuvant therapy in the management of locally advanced renal cell carcinomaKidney function outcomes following thermal ablation of small renal massesOn the occasion of world kidney day 2016; work together to better protect the kidneyRole of kidney injury in sepsisCardiac and vascular changes with kidney transplantationCrosstalk between the heart and peripheral organs in heart failureMacrophage Migration Inhibitory Factor in Clinical Kidney DiseaseCardiovascular risk factors following renal transplantChinese guidelines on the management of renal cell carcinoma (2015 edition)Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.Strategies for Controlling Blood Pressure and Reducing Cardiovascular Disease Risk in Patients with Chronic Kidney DiseaseRenocardiac syndromes: physiopathology and treatment stratagemsInterdisciplinary care clinics in chronic kidney diseaseThe role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspectiveCellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
P2860
Q22251459-52E0C7C3-94BB-440A-9EA7-0A3218CD4513Q22306356-538DAF06-F305-4936-8EC2-52FC918C7B66Q24186190-59437595-C233-46F3-957D-73080936AAD6Q24186226-642631AA-963B-4C36-ACF6-AC71C7EAD720Q24187446-134574E5-1EF3-450D-95F3-E526560297D2Q24188104-C1C8AF00-827F-4AC4-B57F-3AC841F0EDEBQ24194514-0EDC0CBF-D3BC-408C-BAA8-A2AD9CE7B455Q24197614-6FEF4871-57C2-4B4D-914B-BF0054721C78Q24198925-206B132E-C8CC-45A5-8CD0-9D17AA2FA40BQ24200752-EF0567DD-EADF-44FE-B1FB-EF284E0061E4Q24201070-5A1E24B3-DD77-470D-8C1A-AF87FFAB717DQ24234115-6398B04E-E78E-4072-9E53-F02E17D7D9AFQ24240554-A0CED74C-0050-47F0-8241-DD78E1507E05Q24241472-C1146BB1-8812-4A72-9B50-3B5FCBFB2871Q24324384-CF55C648-04FF-4558-AA6B-3DAA2E12B3C4Q24521489-67B638AC-62E1-4716-9CB2-3F421CBC23EEQ24630646-BE4F3AAE-8AC3-49EB-9E51-51A8B0EBB025Q24645222-CE2E515F-B59C-4B43-8878-70F07453E6BEQ24646339-3272F9E2-06AE-4E88-9458-5CCCF6856687Q24657844-8ED9DA52-01A8-4534-ADD4-F99D9055B464Q26471859-F356A279-76A0-4B52-918A-2C1054900F9BQ26740414-410BD44B-6822-492E-9649-715ADE3B5696Q26748846-CB70C076-8B6F-4E17-8D32-F3E2AC47F98FQ26748996-E2BEB414-2F42-4427-846A-44C3AF5DD6E5Q26749084-22A6BA79-0240-4400-8621-B57F833C2B3FQ26751526-CE2AB2B1-783D-417D-B92D-B7DD59D456C7Q26751527-3B4BBCF8-DB3A-4A90-9D37-2EAF5A61ECB6Q26751630-B3B51116-E2C2-42B6-9F18-2BA18494ABEBQ26764943-2C00B9E6-D7FA-45E2-99E3-CCA558232421Q26766491-0E1542D3-5B46-407E-A171-4D72340CB3E7Q26767479-E6CC2DAF-9E83-4117-9ED1-EF0A5B9E797AQ26771406-795DAE8D-297E-44CB-8DE2-17D303A667B6Q26772206-AAD41ED6-EEF5-46E7-9B8A-98A881E3491BQ26773120-4735FFA2-5F79-45B5-BEF3-945B87CBABC2Q26775393-C46B5E49-008B-4421-BEF2-C408350027CFQ26781936-4DA725E5-90DE-47DC-BC0C-B526DE09208FQ26784077-650791C0-68FF-4F45-89E8-DED1D68BAB64Q26795563-DFE914BD-0DF5-4801-BB2D-CBA9540A8A63Q26798487-918EF13C-E26D-486A-BBC4-DB4C04D832A5Q26799916-C131E051-FFE5-4A78-9677-5EE634DB34C2
P2860
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@ast
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@en
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@nl
type
label
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@ast
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@en
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@nl
prefLabel
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@ast
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@en
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@nl
P2093
P3181
P356
P1476
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
@en
P2093
Charles E McCulloch
Chi-yuan Hsu
Dongjie Fan
Glenn M Chertow
P304
P3181
P356
10.1056/NEJMOA041031
P407
P577
2004-09-23T00:00:00Z